🔎 Trials Near Me

Hjem › Type 2-diabetes › Texas › San Antonio

Kliniske studier for Type 2-diabetes i San Antonio, TX

37 studier for Type 2-diabetes søker deltakere på steder i og rundt San Antonio (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.

Offisiell studietekst (engelsk)

Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →

Research Study on How People With Type 2 Diabetes Tolerate Switching From Semaglutide to Cagrisema

RekruttererFase 3
  • NE Clin Res of San Antonio, San Antonio
Alder 18 og eldre · Alle kjønn · Oppdatert 30. sep. 2026 · NCT07817251

EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease

RekruttererFase 3
  • IMA Clinical Research San Antonio, San Antonio
  • Pinnacle Clinical Research, LLC, San Antonio
  • University of Texas Health Science Center at San Antonio, San Antonio
  • og 3 flere
Alder 18 og eldre · Alle kjønn · Oppdatert 30. sep. 2026 · NCT07064473

A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar

RekruttererFase 3
  • Pinnacle Clinical Research - San Antonio, San Antonio
  • Pinnacle Clinical Research, LLC, San Antonio
  • Consano Clinical Research, Shavano Park · 12 mi unna
Alder 18 og eldre · Alle kjønn · Oppdatert 30. sep. 2026 · NCT07754461

Study of ALV-100 to Assess Safety, Tolerability, and PK/PD in Overweight/Obese Participants With or Without T2D

RekruttererFase 1
  • Endeavor Clinical Trials, San Antonio
Alder 18 til 65 · Alle kjønn · Oppdatert 28. sep. 2026 · NCT07399678

A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity

RekruttererFase 3
  • VIP Trials, San Antonio
Alder 18 og eldre · Alle kjønn · Oppdatert 28. sep. 2026 · NCT07595549

A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes

RekruttererFase 3
  • IMA Clinical Research San Antonio, San Antonio
Alder 18 og eldre · Alle kjønn · Oppdatert 22. sep. 2026 · NCT07282600

A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight

RekruttererFase 3
  • Research Site, San Antonio
  • Research Site, San Antonio
  • Research Site, San Antonio
Alder 18 og eldre · Alle kjønn · Oppdatert 22. sep. 2026 · NCT07784270

Pre-diabetes in Subject With Impaired Fasting Glucose (IFG) and Impaired Glucose Tolerance (IGT)

RekruttererFrivillige helsepersonell ønskes velkommen
  • The University of Texas Health Science Center at San Antonio, San Antonio
Alder 18 til 65 · Alle kjønn · Oppdatert 22. sep. 2026 · NCT02969798

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes

RekruttererFase 3
  • AURORA-2 Clinical Site, San Antonio
  • AURORA-2 Clinical Site, San Antonio
Alder 18 og eldre · Alle kjønn · Oppdatert 16. sep. 2026 · NCT07743450

A Study of CX11 Tablets in Patients With Type 2 Diabetes Mellitus

RekruttererFase 2
  • AES - DRS - Synexus Clinical Research US, Inc. - San Antonio, San Antonio
  • Flourish Research - San Antonio - PPDS, San Antonio
Alder 18 til 75 · Alle kjønn · Oppdatert 15. sep. 2026 · NCT07340320

A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes

RekruttererFase 3
  • Pinnacle Clinical Research - San Antonio, San Antonio
Alder 18 og eldre · Alle kjønn · Oppdatert 14. sep. 2026 · NCT07351058

A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide

RekruttererFase 2
  • Consano Clinical Research, LLC, Shavano Park · 12 mi unna
Alder 18 til 75 · Alle kjønn · Oppdatert 14. sep. 2026 · NCT06897475

A Research Study Comparing How Well Different Doses of the Medicine NNC0662-0419 Lower Blood Sugar in People With Type 2 Diabetes

RekruttererFase 2
  • Consano Clinical Research, LLC, Shavano Park · 12 mi unna
Alder 18 til 75 · Alle kjønn · Oppdatert 11. sep. 2026 · NCT07415954

Study to Assess the Effects of ALN-ANG3 in Adult Participants With Diabetic Kidney Disease

RekruttererFase 2
  • Clinical Advancement Center, San Antonio
  • University of Texas Health - San Antonio, San Antonio
Alder 18 til 80 · Alle kjønn · Oppdatert 11. sep. 2026 · NCT07271186

A Research Study Comparing How Well Different Doses of the Medicine UBT251 Lower Blood Sugar in People With Type 2 Diabetes

RekruttererFase 2
  • Quality Research Inc, San Antonio
  • Tekton Research Inc, San Antonio
  • Consano Clin Res-Shavano Park, Shavano Park · 12 mi unna
Alder 18 til 75 · Alle kjønn · Oppdatert 11. sep. 2026 · NCT07668388

A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus

RekruttererFase 3
  • Research Site, San Antonio
  • Research Site, San Antonio
Alder 18 og eldre · Alle kjønn · Oppdatert 9. sep. 2026 · NCT07662213

Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)

RekruttererFase 2
  • Diabetes & Glandular Disease Clinic, P.A., San Antonio
  • Texas Valley Clinical Research - San Antonio TX, San Antonio
Alder 18 og eldre · Alle kjønn · Oppdatert 9. sep. 2026 · NCT07296484

A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Placebo in Children and Adolescents With Type 2 Diabetes

RekruttererFase 3
  • Consano Clinical Research, LLC, Shavano Park · 12 mi unna
Alder 10 til 18 · Alle kjønn · Oppdatert 9. sep. 2026 · NCT07282613

A Study of Macupatide (LY3532226) and Eloralintide (LY3841136), Alone or in Combination, in Adults With Obesity or Overweight and With Type 2 Diabetes

RekruttererFase 2
  • Consano Clinical Research, LLC, Shavano Park · 12 mi unna
Alder 18 til 75 · Alle kjønn · Oppdatert 8. sep. 2026 · NCT07215559

AMBITION 7: A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Insulin Glargine in People With Type 2 Diabetes and Increased Risk of Diseases That Affect the Heart and Blood Vessels Treated With 1-3 Other Diabetes Medications

RekruttererFase 3
  • Clinical Advancement Center, San Antonio
  • The IMA Group IMA Clinical Trials of America Inc. CTA, San Antonio
  • Univ Of Texas Hlth Science Cntr, San Antonio
  • og 2 flere
Alder 45 og eldre · Alle kjønn · Oppdatert 1. sep. 2026 · NCT07797335

A Phase III Study to Investigate the Efficacy and Safety of the Combination of Elecoglipron and Dapagliflozin in Adults With Type 2 Diabetes Mellitus

RekruttererFase 3
  • Research Site, San Antonio
Alder 18 og eldre · Alle kjønn · Oppdatert 31. aug. 2026 · NCT07662109

Quantifying Hepatic Mitochondrial Fluxes in Humans

RekruttererFase 4
  • Texas Diabetes Institute - University Health System, San Antonio
  • University of Texas Health Science Center at San Antonio, San Antonio
Alder 18 til 80 · Alle kjønn · Oppdatert 17. aug. 2026 · NCT05305287

A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus on Background Insulin

RekruttererFase 3
  • Research Site, San Antonio
Alder 18 og eldre · Alle kjønn · Oppdatert 4. aug. 2026 · NCT07664553

Evaluation of the Fully Closed Loop Omnipod® System in Type 2 Diabetes

Rekrutterer
  • Tekton Research, San Antonio
Alder 18 til 75 · Alle kjønn · Oppdatert 3. aug. 2026 · NCT07521475

SALUD-M: Acceptance Based Coping Skills for Hispanic/Latinx Military Patients With Type 2 Diabetes

Rekrutterer
  • Brooke Army Medical Center, San Antonio
Alder 18 til 70 · Alle kjønn · Oppdatert 28. jul. 2026 · NCT07674628

SGLT2i, Ketoacidosis, Volume Contraction, and Insulinopenia

RekruttererFase 1
  • Texas Diabetes Institute/UH, San Antonio
Alder 30 til 75 · Alle kjønn · Oppdatert 17. jul. 2026 · NCT07053306

SGLTi, Hepatic Glucose Production and Ketogenesis

RekruttererFase 1
  • Texas Diabetes Institute/UH, San Antonio
Alder 30 til 75 · Alle kjønn · Oppdatert 17. jul. 2026 · NCT05960656

SGLT2i, Hepatic Glucose Production, and SNS

RekruttererTidlig fase 1
  • Texas Diabetes Institute/UH, San Antonio
Alder 30 til 75 · Alle kjønn · Oppdatert 17. jul. 2026 · NCT07053293

SGLT2i, Pioglitazone, and Ketone Production in T2D

RekruttererFase 1
  • Texas Diabetes Institute/UH, San Antonio
Alder 30 til 75 · Alle kjønn · Oppdatert 17. jul. 2026 · NCT07053319

Phase 2 Trial of Icovamenib in Participants With Type 2 Diabetes Mellitus Who Are Not Achieving Glycemic Targets While Using GLP-1-Based Therapy

RekruttererFase 2
  • Diabetes & Glandular Disease Clinic, P.A., San Antonio
Alder 18 til 70 · Alle kjønn · Oppdatert 15. jun. 2026 · NCT07502508

HP-211 Safety and Proof of Concept Dose Ranging Study in Patients With Type 2 Diabetes

RekruttererFase 2
  • Tekton Research, San Antonio
Alder 18 og eldre · Alle kjønn · Oppdatert 23. apr. 2026 · NCT07546929

ROME GS System Study

Rekrutterer
  • Flourish Research - San Antonio, San Antonio
Alder 18 og eldre · Alle kjønn · Oppdatert 21. apr. 2026 · NCT07518004

Glycemic and Weight Loss Effects of GLP-1R Agonist Therapy in Subjects With Spinal Cord Injury and Type 2 Diabetes

RekruttererFase 4
  • University Health - Texas Diabetic Institute, San Antonio
  • University of Texas Health Science Center at San Antonio, San Antonio
Alder 18 til 70 · Alle kjønn · Oppdatert 13. apr. 2026 · NCT06706284

Comparative Effectiveness of Two Initial Combination Therapies in Patients With Recent Onset Diabetes

RekruttererFase 3
  • University Health System Texas Diabetic Institute, San Antonio
  • UT Health Science Center, San Antonio
Alder 18 til 75 · Alle kjønn · Oppdatert 10. mar. 2026 · NCT06246799

Acute and Chronic Effects of Oral Ketones in Subjects With HFrEF and Diabetes

RekruttererTidlig fase 1
  • University of Texas Health Science Center at San Antonio, San Antonio
Alder 18 til 80 · Alle kjønn · Oppdatert 21. jan. 2026 · NCT06108076

Type 2-diabetes-studier i andre byer

Andre studier i San Antonio

Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.